Effects of LP.8.1-adapted mRNA vaccination on SARS-CoV-2 variant neutralisation - 18/12/25
Doi : 10.1016/S1473-3099(25)00690-5
Christine Happle a, b, d, †, Markus Hoffmann e, †, Metodi V Stankov a, Inga Nehlmeier e, Amy Eichmann f, Torsten Witte a, c, Luis Manthey a, Stefan Pöhlmann e, f, Alexandra Dopfer-Jablonka a, g, ‡, Georg M N Behrens a, c, g, h, ‡ 
a Department of Rheumatology and Immunology, Hannover Medical School, Hannover 30625, Germany
b Department of Pediatric Pulmonology, Allergology, and Neonatology, Hannover Medical School, Hannover 30625, Germany
c Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover 30625, Germany
d German Center for Lung Research, Biomedical Research in End-stage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany
e Infection Biology Unit, German Primate Centre, Leibniz Institute for Primate Research, Göttingen, Germany
f Faculty of Biology and Psychology, Georg-August-University Göttingen, Göttingen, Germany
g German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Hannover, Germany
h CiiM, Centre for Individualized Infection Medicine, Hannover, Germany
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
© 2026
Elsevier Ltd. Tous droits réservés.
Vol 26 - N° 1
P. e3-e5 - janvier 2026 Retour au numéro
Article précédent
- Epidemiological and virological update on the emerging SARS-CoV-2 variant BA.3.2
- Lu Zhang, Nianzhen Chen, Amy Eichmann, Inga Nehlmeier, Anna-Sophie Moldenhauer, Metodi V Stankov, Christine Happle, Alexandra Dopfer-Jablonka, Georg M N Behrens, Markus Hoffmann, Stefan Pöhlmann
- Artificial intelligence and spillover prediction: aligning innovation with empirical reality in One Health surveillance
- Nader Ebrahimi, Amir Ghaemi
Bienvenue sur EM-consulte, la référence des professionnels de santé.